Valuation : Virbac

Market Cap 270.18Cr 314.02Cr 253.55Cr 231.97Cr 432.97Cr 30TCr 436.4Cr 3TCr 1.17TCr 15TCr 1.18TCr 1.15TCr 49TCr P/E 2026 *
15.8x
P/E 2027 * 14.3x
Enterprise Value 282.86Cr 328.75Cr 265.44Cr 242.86Cr 453.28Cr 31TCr 456.87Cr 3.14TCr 1.22TCr 16TCr 1.23TCr 1.21TCr 51TCr EV / Sales 2026 *
1.82x
EV / Sales 2027 * 1.69x
Free-Float
49.03%
Yield 2026 *
0.53%
Yield 2027 * 0.63%
1 day-0.47%
1 week-0.62%
Current month-0.47%
1 month-4.89%
3 months-5.87%
6 months-8.15%
Current year-10.21%
1 week 317.5
Extreme 317.5
327
1 month 317.5
Extreme 317.5
348.5
Current year 312.5
Extreme 312.5
389.5
1 year 296
Extreme 296
389.5
3 years 239
Extreme 239
400
5 years 215
Extreme 215
448.5
10 years 102.1
Extreme 102.1
448.5
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Date Insider Type Main position Quantity % Market Cap. Importance
22/04/24 Sell

Chief Executive Officer

810 0.0096%
22/04/24 Sell

Chief Executive Officer

140 0.0017%
22/04/24 Sell

Chief Executive Officer

1,688 0.0200%
Change 5-day change 1-year change 3-year change Capi.($)
-0.47%-0.62%-1.08%+19.11% 313.19Cr
-0.09%+1.21%-50.19%-60.13% 3.15TCr
-2.33%-2.20%+38.04%+98.26% 1.23TCr
-3.69%-1.53%-15.90%+3.47% 383.1Cr
-3.60%-2.76%+46.90%+30.40% 199.62Cr
0.00%-2.67%+14.42%+6.00% 190.33Cr
-3.68%+5.79%+0.68%+186.34% 162.08Cr
-3.25%+2.43%-20.28%-9.25% 120.53Cr
-1.46%-2.32%-10.95%-42.01% 102.56Cr
0.00%-1.27%-3.45%-20.75% 94Cr
Average -1.78%-0.88%-0.18%+21.14% 594.62Cr
Weighted average by Cap. -1.08%-1.59%-18.36%-5.17%

Financials

2026 *2027 *
Net sales 155.09Cr 180.26Cr 145.54Cr 133.16Cr 248.54Cr 17TCr 250.5Cr 1.72TCr 670.5Cr 8.71TCr 676.9Cr 662.14Cr 28TCr 164.73Cr 191.46Cr 154.59Cr 141.43Cr 263.98Cr 18TCr 266.07Cr 1.83TCr 712.17Cr 9.25TCr 718.96Cr 703.28Cr 30TCr
Net income 17Cr 20Cr 16Cr 15Cr 27Cr 1.88TCr 28Cr 189.96Cr 74Cr 960.76Cr 75Cr 73Cr 3.09TCr 19Cr 22Cr 18Cr 16Cr 30Cr 2.08TCr 31Cr 210.42Cr 82Cr 1.06TCr 83Cr 81Cr 3.43TCr
Net Debt 13Cr 15Cr 12Cr 11Cr 20Cr 1.39TCr 20Cr 140.7Cr 55Cr 711.64Cr 55Cr 54Cr 2.29TCr 7.52Cr 8.74Cr 7.05Cr 6.45Cr 12Cr 825.76Cr 12Cr 83Cr 32Cr 421.99Cr 33Cr 32Cr 1.36TCr
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
03/26/03 321.00 -0.47% 3,069
02/26/02 €322.50 0.00% 4,027
01/26/01 €322.50 0.00% 3,810
31/26/31 €322.50 -0.31% 4,795
28/26/28 €323.50 +0.15% 3,313
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
322.50EUR
Average target price
411.88EUR
Spread / Average Target
+27.71%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIRP Stock